The Real-World Use of Semaglutide to Promote Weight Loss in Obese Adults With Hemodialysis: A Multicenter Cross-Sectional Descriptive Study
This study suggests that semaglutide promotes weight loss in hemodialyzed adults with obesity, but discontinuation of treatment was frequent and common adverse events were reported.
Authors
- J Doucet
- Jodianne Couture
- Janie Beauregard
- Jacynthe Lafrenière
- Annie Lizotte
- Marie-France Beauchesne (ORCID: https://orcid.org/0000-0001-7923-2506)
- Gabriel Dallaire (ORCID: https://orcid.org/0000-0001-9333-3039)
- P Robert
Institutions
- Centre Hospitalier Universitaire de Sherbrooke (CA)
- Centre Integre de Sante et de Services Sociaux de Laval (CA)
- Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec (CA)
- Centre Intégré de Santé et de Services Sociaux du Bas-Saint-Laurent (CA)
- Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal (CA)
- Dr. Georges-L.-Dumont University Hospital Centre (CA)
- Université Laval (CA)
- Centre intégré universitaire de santé et de services sociaux du Nord-de-l’Île-de-Montréal
- Université de Montréal (CA)
Publication Details
- Journal
- Canadian Journal of Kidney Health and Disease
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1177/20543581251324588
- Citations
- 5
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 6.47